DekaBank Deutsche Girozentrale
ENZN

DekaBank Deutsche Girozentrale’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-25,100
Closed -$29K – 1010
2013
Q4 		$29K Buy
25,100
+500
+2% +$770 ﹤0.01% 891
2013
Q3 		$41K Buy
+24,600
New +$45.5K ﹤0.01% 842

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ENZN Position: Q1 2014 in Review

DekaBank Deutsche Girozentrale sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q1 2014, closing a stake of 25,100 shares — an estimated $29K sold.

DekaBank Deutsche Girozentrale first reported a position in ENZN in Q3 2013 and held it in 2 quarters. The position peaked at $41K in Q3 2013. 75 funds tracked by Wall St. Rank hold ENZN as of Q1 2014.

  • DekaBank Deutsche Girozentrale reported no remaining ENZON PHARMACEUTICALS INC position as of Q1 2014 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 25,100 ENZON PHARMACEUTICALS INC shares in Q1 2014, an estimated $29K.
  • DekaBank Deutsche Girozentrale first reported a position in ENZON PHARMACEUTICALS INC in Q3 2013 and held it in 2 quarters.
  • DekaBank Deutsche Girozentrale's ENZON PHARMACEUTICALS INC position peaked at $41K in Q3 2013.
  • 75 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q1 2014.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2014, filed 15 May 2014.